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Two unrelated 8-month-old male mixed breed dogs were presented for evaluation of progres-
sive ataxia, knuckling, and lack of pain perception in the distal limbs. Because of the similarity in
age of onset, progression, and clinical findings with previously described sensory neuropathy in
Border Collies, the affected dogs were screened for an FAM134B mutation and were deter-
mined to be homozygous for the mutation. Despite few phenotypic similarities with other
breeds, genetic testing for specific diseases should be considered in mixed breed dogs with
compatible clinical signs, especially if ancestry is unknown.
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1 | CASE 1
An 8-month-old male intact mixed-breed dog was referred to the
Neurology Service of the University of Glasgow for investigation of a
1-month history of chronic progressive gait abnormalities. The owners
had noticed that the dog was chewing its paw for 3–4 months before
referral and then developed gradually deteriorating ataxia and knuck-
ling over in the pelvic limbs during the month before evaluation. At
that stage, urinary incontinence also was observed, with the dog pass-
ing urine intermittently, even when walking. CBC and serum biochem-
istry were unremarkable. Radiographs of the thoracolumbar vertebral
column were obtained and no abnormalities were detected. No
information was available regarding ancestors or other littermates, but
the circumstances suggested that the puppy was from a farm.
Physical examination findings included multiple wounds on the
distal aspect of all 4 limbs. Neurological examination identified normal
mentation and cranial nerve function. Gait assessment disclosed
severe proprioceptive ataxia in all limbs with the pelvic limbs more
severely affected including occasional knuckling of the hind paws.
Paw positioning and hopping were decreased to absent in all limbs.
Withdrawal reflex was absent in all limbs, but patellar, perineal, and
cutaneous trunci reflexes were intact. Superficial and deep pain per-
ception was absent distally in all limbs but present proximally, and in
the tail, trunk, and head. Findings were consistent with a peripheral
sensory neuropathy with partial autonomic involvement as suggested
by the urinary incontinence.Abbreviation: CBC, complete blood cell count
Received: 2 April 2018 Revised: 19 May 2018 Accepted: 31 July 2018
DOI: 10.1111/jvim.15312
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any
medium, provided the original work is properly cited and is not used for commercial purposes. © 2018 The Authors. Journal of Veterinary Internal Medicine published
by Wiley Periodicals, Inc. on behalf of the American College of Veterinary Internal Medicine.
2082 wileyonlinelibrary.com/journal/jvim J Vet Intern Med. 2018;32:2082–2087.
Repeated CBC and serum biochemistry profile did not identify
any abnormalities. Serology testing for Toxoplasma gondii and Neos-
pora caninum was negative. Electromyography disclosed mild sponta-
neous electrical activity in multiple distal appendicular muscles in all
limbs. Motor nerve conduction velocity of the ulnar, sciatic, and com-
mon fibular nerves was within normal range. Muscle cryosections
from the biceps femoris and gastrocnemius muscles were evaluated
using a standard panel of histochemical stains and reactions. No spe-
cific abnormalities were identified in either muscle. A formalin-fixed
biopsy from the common fibular nerve was embedded in resin and
evaluated using 1 μm sections (Figure 1). Multifocal areas of nerve
fiber loss were present without obvious axonal degeneration or demy-
elination. It could not be determined if areas of nerve fiber loss
involved mainly sensory or motor fibers in this mixed nerve. To our
knowledge, a method of distinguishing motor from sensory fibers his-
tologically in a mixed nerve is not available. A sensory nerve would
have provided clarification but was not submitted for evaluation. A
presumptive diagnosis of sensory neuropathy was established.
To decrease the frequency and severity of mutilations, treatment
with pregabalin (Pregabalin Teva 25 mg capsules, TEVA UK Limited,
Eastbourne, United Kingdom) was initiated (2 mg/kg PO q8h). Unfor-
tunately, clinical signs continued to progress despite treatment, and
the owner requested a second opinion from the neurology service of
Fitzpatrick Referrals. Repeated neurological examination suggested
progression of signs. The urinary incontinence was more pronounced
and compatible with an autonomic bladder, with frequent pollakiuria,
and fecal incontinence was present. The dog was indifferent to distal
painful stimuli and had absent withdrawal reflexes in all 4 limbs. How-
ever, a behavioral response was observed to a painful stimulus when
applied proximally on the thoracic limbs, with a very slight withdrawal
reflex. Nociception was still present in the tail. Cutaneous trunci reflex
was absent caudal to the level of the T10 vertebra. The perineal
reflex, despite fecal incontinence, was intact. Patellar reflexes were
absent. Cranial nerve function including facial sensation was intact.
The dog failed to correct a knuckled over paw, in the thoracic limbs as
well as in the pelvic limbs. The dog did, however, place the thoracic
limbs normally and had normal hopping ability. Hopping ability was
absent in the pelvic limbs. In addition, the dog recurrently chewed on
its limbs. Unfortunately, clinical signs continued to progress and the
owners elected euthanasia 4 months after the first neurological
consultation.
Because of clinical and histopathological similarities with previ-
ously reported Border Collie sensory neuropathy1 and despite the fact
that the dog did not resemble a Border Collie (Figure 2), it was
decided to screen for the recently reported mutation in the FAM134B
gene and the dog was found to be homozygous.
2 | CASE 2
An 8-month-old male intact mixed-breed dog of unknown ancestry
was presented to the Neurology Service of Northwest Veterinary
Specialists for evaluation of gait abnormalities similar to those of Case
1. The owners initially observed the clinical signs when the dog was
approximately 6.5 months of age. Pelvic limb ataxia and occasional
spontaneous knuckling were observed. Trial treatment with meloxi-
cam (Metacam 1.5 mg/mL oral solution, Boehringer Ingelheim, United
Kingdom; 0.2 mg/kg PO q24h for 7 days) followed by a combination
of prednisolone (Prednisolone tablets B.P. [Vet], Millpledge Veteri-
nary, United Kingdom; 1 mg/kg PO q12h for 5 days followed by
1 mg/kg PO q48h) and clindamycin (Clinacin tablets, Chanelle, United
Kingdom; 7.5 mg/kg PO q12h for 5 days) was not effective, clinical
signs progressively worsened, and the medications were discontinued.
On referral, the patient had severe gait disturbance and was almost
consistently standing on the dorsal aspects of its pelvic digits. The
owner also described the occurrence of defecation during walking.
Physical examination disclosed multiple wounds in the distal
aspect of all 4 limbs. Neurological examination identified normal men-
tation and cranial nerve function. Gait assessment disclosed severe pro-
prioceptive ataxia in all limbs. The pelvic limbs were more severely
affected, with bilateral hyperextended tarso-crural joints and standing
on the dorsal aspect of the pelvic digits. Severe valgus deformity of
both carpi was present. Paw positioning and hopping were absent in
the pelvic limbs and decreased in the thoracic limbs. The withdrawal
reflex was absent in all limbs, but patellar and perineal reflexes were
intact. Deep and superficial pain perception was absent distally in all
limbs and in the tail, but present proximally and in the trunk and head.
The findings were consistent with a peripheral sensory neuropathy with
partial autonomic involvement, as suggested by fecal incontinence.
A CBC and serum biochemistry profile did not identify any abnor-
malities, except for a mild increase in creatine kinase activity of
465 U/L (normal ≤190 U/L). Serology testing for T. gondii and N. cani-
num was negative. Again, because of the clinical similarities with previ-
ously reported Border Collie sensory neuropathy,1 the dog was
FIGURE 1 Resin-embedded thick sections (1 μm) of a common fibular
nerve fascicle stained with toluidine blue-acid fuchsin. Numerous
collagenous bundles consistent with resolving subperineurial edema
are present in the subperineurium. Arrows depict representative areas
of nerve fiber loss. The distribution of sensory and motor nerve fibers
in this mixed nerve could not be determined
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screened for the recently reported mutation in the FAM134B gene
and found to be homozygous. Phenotypically, the dog did not resem-
ble a Border Collie (Figure 3). The dog was lost to follow-up, and the
post-mortem examination was declined by the owner.
Herein we describe 2 cases of sensory neuropathy caused by an
inversion disrupting FAM134B in a dog other than a pure-breed Bor-
der Collie. Sensory neuropathy in the Border Collie is an autosomal
recessive disease characterized by chronic and progressive proprio-
ceptive ataxia, proprioceptive deficits, loss of nociception, self-
mutilation, and in some cases, autonomic signs such as urinary
incontinence.1–4 Recently, a genetic mutation was found affecting the
FAM134B gene in Border Collies with clinical signs compatible with
sensory neuropathy.1 The FAM134B gene encodes a cis-Golgi protein
found in sensory and autonomic neurons. Although not completely
understood, this defect induces apoptosis in neurons of the dorsal
root ganglia.1
Sensory neuropathies with or without autonomic involvement have
been reported in other canine breeds, such as long-haired Dachshund,5,6
FIGURE 2 Diagram showing the ancestors of Case 1: 37.5% corresponded to Border Collie, 25% to Bichon Frise, and the rest (37.5%) to mixed
breed groups
FIGURE 3 Diagram showing the ancestors of the Case 2: 25% corresponded to Border Collie, 37.5% mixed breed groups, 25% Parson Russell
Terrier, and 12.5% Labrador Retriever
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Miniature Pinscher,7 and Jack Russell Terrier8 in which the responsible
genetic mutation has not yet been identified, and in the Pointer,9–12
English Springer Spaniel, and French Spaniel13 breeds in which a muta-
tion in the GDNF gene recently has been identified (Table 1).14 A neuro-
degenerative disease affecting central and peripheral sensory and motor
axons has been reported in Golden Retriever dogs and is caused by a
deletion in the mitochondrial tRNATyr gene.15,16
Hereditary sensory and autonomic neuropathies (HSAN) are well
described in humans and represent a group of seven (I-VII) disorders
characterized by progressive sensory loss and ulcerative mutilation in
combination with variable autonomic and motor disturbances associ-
ated with sensory and autonomic dysfunction.17,18 Molecular genetics
studies have identified disease-causing mutations in 12 genes. Some
of the affected proteins have nerve-specific roles, for example, nerve
growth factor and receptor. Underlying mechanisms also have been
shown to involve sphingolipid metabolism, vesicular transport, struc-
tural integrity, and transcription regulation.19 Interestingly, although
most of these disorders are autosomal recessive (II-VI), HSAN Types I
and VII are dominant disorders. Type I HSAN is caused by a mutation
in the SPTLC1 gene. This gene encodes a serine palmitoyltransferase
responsible for the synthesis of sphingolipids, ceramide, and sphingo-
myelin.20 Similar to the sensory neuropathy in the Border Collie,
FAM134B gene mutations have been found to cause HSAN II21 and
play a role in the etiology of some types of neoplasia such as esopha-
geal squamous cell carcinoma and colorectal cancer in people.22,23 A
previous study in mice showed high expression of this gene in the
dorsal root ganglia and reported that nociceptive neurons seem to be
especially sensitive to deletion of FAM134B, therefore causing the
characteristic clinical signs of HSAN II.21 Separately, from HSAN,
Charcot-Marie-Tooth (CMT) disease, is one of the most common
TABLE 1 Hereditary sensory neuropathies previously described in dogs
Breed Border Collie1–4
Jack Russell
Terrier8
Long-haired
Dachshund5,6 Pointer dogs11 French Spaniel13
Miniature
Pinscher7
Age of
presentation
2-7 months 6 yearsa 8-12 weeks 2-12 months 3.5-12 months 6 monthsa
Clinical signs • Proprioceptive
ataxia
• Knuckling
• Hyperextension
of limbs
• Decreased or
loss of
proprioception
and nociception
• Autonomic
signs such as
urinary/fecal
incontinence
• Self-mutilation
• Hypermetric
gait
• Proprioceptive
deficits
• Loss of
nociception
• Proprioceptive
ataxia
• Decreased or loss
of proprioception
and nociception
• Autonomic signs
such as vomiting
or urinary
incontinence
• Self-mutilation
• Decreased pain
perception
proximal to the
carpus and tarsus.
• Loss of pain
perception to the
distal aspect of
the paw.
• Self-mutilation
• Similar to
Pointer dogs
• Decreased pain
perception in
the distal pelvic
limbs
• Hyperesthesia
on palpation of
the lumbar
region
• Self-mutilation
Diagnosis • Decreased or
absent sensory
nerve
compound
action
potentials
• Decreased or
normal motor
nerve
conduction
velocities
Unknown • Decreased of
absent sensory
nerve compound
action potentials
• Normal
electromyography
• Normal
electrodiagnostics
• Normal
electrodiagnostics
Unknown
Treatment Unknown Unknown Unknown Unknown Unknown Unknown
Histopathology • Axonal
degeneration
• Endoneurial
fibrosis
• Extensive large
nerve fiber loss
• Endoneurial
and epineurial
fibrosis
• Decreased
number of
myelinated fibers
• Degeneration of
unmyelinated
axons, most
predominant
distally.
• Decreased
number of
ganglionic cell
bodies without
remarkable
neuronal
degeneration
• Reduced fiber
density and
myelin staining in
the spinal cord
• Lack of staining
for substance P in
the spinal cord
• No abnormalities
were detected
• Reduced
number of
neurons in the
lumbosacral
spinal ganglia
• Loss of nerve
fibers and
endoneurial
proliferation
with Wallerian
degeneration in
the dorsal
nerve roots
Genetic
mutation
identified in
FAM134B Unknown Unknown GDNF GDNF Unknown
a The age of presentation in Jack Russell Terrier and Miniature Pinscher remains unclear as this disease has been reported in one single case in both
breeds.7,8 In the Jack Russell, although the clinical signs worsened when the dog was 6 years old, progressive abnormal pelvic limb posture was noticed
since birth. In the Miniature Pinscher, the dog presented at 18 months of age, although the clinical signs were first noticed 12 months prior.
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motor and sensory inherited neuropathies in humans.24 Affected peo-
ple can present with a primary axonopathy or an axonopathy second-
ary to a myelination defect in Schwann cells.25 Multiple studies have
been performed and several genetic defects have been encountered.
For example, approximately 75% of cases of the demyelinating form
(CMT1) are caused by duplication in the short arm region of chromo-
some 17 in combination with mutations in PMP22, MPZ, or GJB.24
Nevertheless, classification of HSAN and CMT still is incomplete, and
some clinical and genetic overlap may exist.
Intriguingly, mutation of FAM134B was responsible for the devel-
opment of disease in these unrelated mixed breed dogs, despite the
fact that they phenotypically looked more like a Jack Russell and a
Parson Russell than a Border Collie, respectively (Figures 2 and 3).
Because we were interested in knowing if the mutation was more
widespread in the canine population than previously thought, or if
there was any Border Collie ancestry in these dogs, a DNA sample
was submitted for a commercially available canine breed ancestry test
(Wisdom Panel, Mars Veterinary, Vancouver, WA, USA). The results
suggested Border Collie ancestry in both dogs (Figures 2 and 3).
However, these results should be interpreted with caution, because to
our knowledge no scientific publications validate the sensitivity or
specificity of the algorithm currently used for this test. Although, most
likely the mutation arose from Border Collie ancestry, it is impossible
to determine this possibility with certainty. The presence of a specific
mutation causing the same neurodegenerative condition in > 1 breed
has been described previously in veterinary medicine. For example,
until recently, all mutations causing neuronal ceroid lipofuscinosis in
dogs were reported to occur in members of a single breed, but 2
recent studies have reported a previously identified mutation in a sec-
ond breed.24,25 The fact that these gene alterations have been
encountered in multiple breeds suggests that these diseases may be a
consequence of more ancient mutations widely spread throughout
the canine population.26
Also as previously reported, hereditary genetic diseases can affect
mixed-breed dogs and characterizing them also may help other
breeds.26–30 In 2 recently published studies, it was found that a large
number of mixed-breed dogs carried autosomal recessive muta-
tions.29,30 In these studies, the same commercially available canine
breed ancestry test (Wisdom Panel, Mars Veterinary) was used, and it
was found that many of the mixed-breed dogs carrying the alternate
or mutant allele had the specific breed, in which the mutation initially
was identified, in their ancestry.29,30
In conclusion, the genetic test for the FAM134B gene mutation is
recommended when clinical signs are compatible with sensory neu-
ropathy. Rare autosomal recessive genetic mutations previously iden-
tified in specific pure-breed dogs should be considered as a
differential diagnosis in mixed-breed dogs with compatible clinical
signs, especially if ancestry is unknown.
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